Echocardiographic evaluation of mitral E/e' as a prognostic indicator in ST-elevation myocardial infarction. by Ramesh, R
 1 
 
ECHOCARDIOGRAPHIC EVALUATION OF MITRAL  
 E/e’ AS A PROGNOSTIC INDICATOR IN 
ST‐ELEVATION MYOCARDIAL INFARCTION 
 
Dissertation submitted to 
 
THE TAMIL NADU DR. M.G.R. MEDICAL UNIVERSITY 
In partial fulfilment of the requirements for the award of the degree of 
 
 
D.M. CARDIOLOGY 
BRANCH II – CARDIOLOGY 
 
MADRAS MEDICAL COLLEGE& 
RAJIV GANDHI GOVERNMENT GENERAL HOSPITAL 
CHENNAI - 600 003 
 
 
 
 
 
 
 
 
 
 
 
 
THE TAMIL NADU DR. M.G.R. MEDICAL UNIVERSITY 
CHENNAI, INDIA 
 
AUGUST 2014 
2 
 
 
 
CERTIFICATE 
 
 
 
This is to certify that the dissertation titled ECHOCARDIOGRAPHIC 
EVALUATION OF  MITRAL  E/e’ AS A PROGNOSTIC 
INDICATOR  IN  ST-ELEVATION  MYOCARDIAL 
INFARCTION is the bonafide original work of     Dr. R.RAMESH,in 
partial fulfillment of the requirements for D.M. Branch-II 
(CARDIOLOGY) examination of THE TAMILNADU DR.M.G.R. 
MEDICAL UNIVERSITY to be held in August 2014.The period of 
post-graduate study and training was from August 2011 to July 2014. 
 
 
 
Prof.R.Vimala , M.D. 
Dean, 
Rajiv Gandhi Government General 
Hospital & Madras Medical 
CollegeChennai - 600 003. 
 
 
 
Prof. M.S.Ravi, M.D, D.M 
 
Professor and  Head of Department 
Department of Cardiology 
Rajiv Gandhi Government General  
Hospital &Madras Medical College, 
Chennai - 600 003. 
 
3 
 
 
DECLARATION 
 
I,  Dr.R.RAMESH, solemnly declare that this dissertation entitled, 
“ECHOCARDIOGRAPHIC EVALUATION OF MITRAL  E/e’ AS 
A PROGNOSTIC INDICATOR IN ST-ELEVATION 
MYOCARDIAL INFARCTION” is a bonafide work done by me at 
the department of Cardiology, Madras Medical College and 
Government General Hospital during the period 2011 – 2014 under the 
guidance and supervision of the Professor and Head of the department 
of Cardiology of  Madras Medical College and Government General 
Hospital, Professor M.S.Ravi, M.D.D.M. This dissertation is submitted 
to The Tamil Nadu Dr.M.G.R Medical University, towards partial 
fulfillment of requirement for the award of D.M. Degree (Branch-II) 
in Cardiology. 
 
 
Place:                                          SIGNATURE OF THE CANDIDATE                                        
Date: 
4 
 
 
ACKNOWLEDGEMENT 
 
 
A great many people made this work possible. I thank Prof.R.Vimala,M.D., 
Dean for allowing me to conduct this study. 
My heartfelt respects and sincere gratitude to our belovedProf .M.S.Ravi, 
Professor and Head of the Department of Cardiology, Government General 
Hospital, Chennai who was the leading light behind this study. But for his 
constant guidance this study would not have been possible. 
I am indebted to , Prof K.Meenakshi, Prof. D.Muthukumar, Prof. 
N.Swaminathan , Prof. G.Ravishankar and Prof.Justin Paulwithout 
whom, much of this work would not have been possible. 
I am thankful toDr.S.Venkatesan for the constructive comments and 
suggestions he made during this project.  
In addition, I am grateful to, Dr.Moorthy, Dr.G.Prathapkumar, 
Dr.C.Elangovan, Dr.Rajasekar Ramesh, Dr.S.Murugan, and Dr.G.Manohar, 
for their guidance. 
I also thank all my patients for their kind cooperation. 
Lastly, I thank all my professional colleagues for their support and valuable 
criticisms
5 
 
 
                                                    CONTENTS  
  PAGE NO 
1. INTRODUCTION 6 
2. AIMS  AND OBJECTIVES 10 
 
3. REVIEW  OF  LITERATURE 11 
4. MATERIALS AND METHODS 33 
  5     ANALYSIS OF RESULTS& DISCUSSION 36 
   
6. CONCLUSIONS 58 
7. LIMITATION OF STUDY 59 
8. APPENDIX 60 
 
a.  Bibliography 
b. Abbreviations and Acronyms 
c. Proforma 
d. Master chart  
e. Ethical committee approval order  
f. Plagiarism Report 
ABBREVIATIONS  AND ACRONYMS 
 
STEMI –ST-elevation Myocardial Infarction 
AMI      - Acute Myocardial Infarction 
TIMI     - Thrombolysis In Myocardial Infarction 
LVEF    - Left Ventricular Ejection Fraction 
MV        - Mitral Valve 
E            - MV early diastolic velocity 
A           -  MV late diastolic velocity 
e ‘         -   Tissue Doppler early diastolic velocity of lateral mitral annulus 
DT        - Deceleration Time  of early diastolic mitral inflow. 
TDI       -Tissue Doppler Imaging 
PCWP   - Pulmonary Capillary Wedge Pressure 
mLVDP – mean LV diastolic Pressure 
LVEDP -  LV End Diastolic Pressure 
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INTRODUCTION 
STEMI is a major public health problem in the developed world and is 
rising in developing countries . In the United States, almost 1 million patients 
per year suffer from an acute MI, and more than 1 million patients with 
suspected acute MI yearly enter coronary care units in the United States. The 
rate of MI rises for both men and women sharply with increasing age, and racial 
differences exist, with MI occurring more frequently in Asian men and women, 
regardless of age . Of particular concern from a global perspective, the burden 
of MI in developing countries may approach those now afflicting developed 
countries. Limitations in available resources to treat STEMI in developing 
countries requires major efforts to strengthen primary prevention programs 
Improvements in Outcome  
Mortality from STEMI has declined steadily. This drop in mortality 
appears to result from a fall in the incidence of STEMI and a fall in the case 
fatality rate once STEMI has occurred. 
Several phases in the management of patients have contributed to the 
decline in mortality from STEMI. The “clinical observation phase” of coronary 
care emerged in the first half of the 20th century and focused on a  recording of 
physical and laboratory findings,. The “coronary care unit phase” began in the 
mid-1960s and was notable for detailed analysis and management of cardiac 
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arrhythmias. The “high-technology phase” heralded by the introduction of the 
invasive balloon catheters set the stage for bedside hemodynamic monitoring 
and more precise hemodynamic management. The modern “reperfusion era” of 
coronary care was introduced by intracoronary and then intravenous 
fibrinolysis, increased use of aspirin, and the development of primary 
percutaneous coronary intervention 
 
RISK ASSESSMENT AFTER ACUTE MYOCARDIAL INFARCTION 
  Patients with ST-elevation myocardial infarction (STEMI) should 
undergo risk stratification soon after presentation. Since most patients with 
STEMI undergo reperfusion therapy, early risk stratification and  late risk 
stratification attempts to identify patients who are at increased risk of death. 
Risk stratification is accomplished with the use of validated risk prediction 
models that include the most important predictors of outcome. 
EARLY RISK STRATIFICATION — All patients with ST-elevation 
myocardial infarction (STEMI) should undergo risk assessment within the first 
four to six hours of hospitalization. However, even low-risk patients should 
undergo primary reperfusion ( with percutaneous coronary intervention or 
thrombolysis) in a timely manner. 
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The TIMI risk score and the GRACE risk model are two commonly used 
scoring systems used in patients with STEMIin  patients admitted with an acute 
myocardial infarction (MI) are categorized into high risk groups on the basis of 
risk factors like age prior MI, Killip class, Anterior MI, Hypotension and 
Tachycardia. 
Clinical utlity of  Echocardiography in Acute Myocardial Infarction. 
  Assessment of resting left ventricular function is an important part of risk 
stratification in patients with acute myocardial infarction . Patients with left 
ventricular systolic dysfunction have increased mortality at six months and one 
year. The increase in mortality is most pronounced in the minority of patients 
with a ejection fraction (EF) ≤30 percent. In addition, patients with EF ≤35 
percent are at increased risk for sudden cardiac death after MI and should be 
considered candidates for appropriate therapy. EF is usually measured before 
discharge. In patients with heart failure or suspected mechanical complication  
echocardiography may be indicated early in the hospitalization. However, 
measurements during hospital stay may be misleading, since improvement in 
EF, beginning within three days and upto 14 days, is common in patients who 
are reperfused. Two separate studies have shown that approximately 58 percent 
of patients significantly improve d EF after reperfusion in acute STEMI. This 
may reflect,  recovery from myocardial stunning since it is associated with a 
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reduction in the size of the myocardial perfusion defect. Patients with improved  
EF may have significantly lower mortality than those who show no 
improvement (1.2 versus 5.6 percent at three years) 
   In the setting of acute myocardial echocardiogram is a favoured 
diagnostic tool to identify poor prognostic factors like right ventricular 
infarctions, mitral regurgitation, left atrial enlargement and diastolic 
dysfunction. 
   Assessment of  diastolic dysfunction with the help of echocardiography is 
used in  the diagnosis of diastolic heart failure (HF)  and elevated filling 
pressures in the LV which is an indirect measure of the Pulmonary Capillary  
Pressure. 
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AIMS & OBJECTIVES  
 
1. To analyze  the clinical characters, in hospital  events in patients    admitted 
with acute wall myocardial infarction (STEMI) evaluated by echocardiographic 
color and tissue doppler E / e’ ratio  evaluation of mitral valve as  a measure of 
left ventricular filling pressure. 
2. To assess the usefulness of E/e’ as a prognostic indicator in patients STEMI 
with or without revascularisation therapy to predict hospital mortality. 
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REVIEW OF LITERATURE 
Variable degrees of systolic dysfunction is prevalent after a myocardial 
injury and the pathophysiological principles s underlying this dysfunction and 
its effect on the outcomes of the patient has been the subject of several path 
breaking studies which have contributed to modification in therapeutic 
strategies in a radical manner. 
 
Moreover, heart failure demonstrated by clinical or radiographic 
evaluations over and above decreased systolic function is strong predictor of 
prognosis after myocardial infarction. Seemingly beningn myocardial damage 
can lead on to signs of pulmonary congestion indicating elevated ventricular 
end diastolic pressure. 
 
This has been attributed to impaired active relaxation of the myocardium 
and increased chamber stiffness leading onto abnormal diastolic function.  
 
This has to be determined by invasive cardiac catheterisation studied with 
the use of micromanometer catheters such an invasive strategy is not practical 
for use on a day to day basis. 
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Similarly directly measuring the right heart or left heart end diastolic 
pressures is useful in predicting  worser outcomes after myocardial infarction. 
Their routine usage is not recommended due to high incidence of complications. 
 
In order to circumvent these issues, the use of non-invasive methods in 
the assessment of diastolic function like Doppler – echo cardiography as a 
surrogate marker of abnormal ventricular filling has come up on a large scale. 
These observations can be used to predict prognosis after myocardial infarction 
in such patient groups. 
 
The following brief discussion about the current understanding of 
ventricular filling after infarction reviews the usage of left atrial volume and 
filling, mitral Doppler dynamics and its abnormal patterns in the setting of an 
acute myocardial injury using two dimensional and Doppler echo cardiography. 
 
Doppler Echocardiography 
  Doppler technique helps in evaluation of flow velocities  by precisely 
locating specific points inside the various regions of the heart and grading the 
flow. 
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Velocity of blood flow across the mitral valve is determined by the ventricular 
negative pressure generated and the difference in pressure between the left 
atrium and ventricle. 
 
This initial phase is followed by a progressive decline in the velocity of 
inflowing blood. This phase has a duration raging from 140-240 milliseconds 
and is called the mitral deceleration time (DT) (Figure 2). After a brief period of 
diastasis, atrial systolic produces an rise in velocity of the inflow which is much 
less than that compared to the early inflow. 
 
As a result, the ratio between the early and late inflow velocities across 
the mitral valve (E/A ratio) is in the range of 1 to 1.5. 
 
The early mitral inflow might decrease as a result of impaired active 
relaxation leading onto augmented atrial contribution to filling of ventricules. 
This causes reversal in the E/A ratio with concomitant prolongation of DT 
(Figure 2). As the diastolic function progressively worsens the left atrial 
pressure begins to rise creating increasing gradient between the left atrium and 
the ventricle. This causes rise in velocity of early inflow even though the active 
relaxation is impaired. As a result of rapid equilibration of pressure, early part 
of the ventricular filling comes to a close prematurely with a decrease in the 
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time period of early diastolic filling returning the DT to normal intervals. This 
seemingly normal mitral inflow pattern even in the presence of impaired 
relaxation and increased left atrial pressure is called the pseudonormal pattern 
(Grade 2 dysfunction) (Figure 1). 
 
With further worsening of active relaxation, early diastolic filling 
abruptly terminates because of worsening left ventricular stiffness. 
 
The deceleration time will be fore shortened and as a result the E/A ratio 
is increased. This pattern is termed restrictive filling (Grade 3 dysfunction) 
(Figure 2). This can assume two forms as reversible and irreversible on the basis 
of response to reduction in preload by treatment or by valsalva maneuver. If 
these interventions cause reversal of the pattern of the filing is called reversible 
and irreversible if these interventions produced on effect. 
 
Although mitral Doppler inflow patterns continue to be the bedrock on 
which ventricular diastolic function can be assessed, there are certain short 
comings to this measurement. They can rapidly change with variations in blood 
volumes. A pseudonormal pattern even in the event of an elevated diastolic 
pressure is another disadvantage. To circumvent these, parameters that are load-
independent can be used like, the Doppler inflow patterns in the pulmonary 
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veins. This is again hampered by irregular heart rates. Other parameters like 
propagation of blood flow into the left ventricle studied the help of color M-
mode. Lastly tissue Doppler evaluation of movement of the mitral annulus in 
the diastolic phase is a promising new modality to assess diastolic function. 
 
FIGURE .1  ECHO  ASSESSMENT OF DIASTOLIC FUNCTION 
 
1. Mitral inflow Doppler depicting E and A waves and DT. 
2. Tissue Doppler of mitral annulus showing e’ velocity. 
3. Color M-mode  showingVp velocity. 
4. 2-D Echo showing LA volume. 
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FIGURE 2.  GRADES OF DIASTOLIC  DYSFUNCTION 
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Tissue   Doppler Echocardiography. 
Myocardial tissue motion can be studied with the aid of tissue Doppler 
imaging which demonstrates the tissue motion parallel to the beam of Doppler 
waves. 
 
The ventricular apex is fixed during cardiac cycle resulting in a 
movement of the basal regions of the ventricle in a parallel direction with the 
long axis of the heart. The ventricular motion along the basal region of the heart 
is an indicator of longitudinal axial contraction. 
 
The early diastolic mitral motion expressed as e’ velocity is a predictable 
indicator of ventricular relaxation. Catherization studies show that e’ has an 
inverse relationship with the measures of ventricular relaxations. These 
velocities are less affected in the presence of changes in ventricular volumes 
and can help in the assessment of pseudonormal ventricular fillings.  
 
The routine use of ratio between E velocity and early diastolic mitral 
tissue velocity (E/e’) in the assessment of ventricular end-diastolic  pressures 
has been extensively studied in several reports. 
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Even in the presence of cofounding factors like atrial fibrillations, tachy 
cardia, normal and abnormal ventricular systolic function, ventricular 
hypertrophy, mitral regurgitation E/e’ was good at predicting end-diastolic 
pressures. (Ommen et al) (9) showed that increased end-diastolic pressure is 
predicted with reasonable accuracy within an narrow range by the measurement 
of E/e’ 
 
The caveat is that tissue Doppler detects the velocity of an actively 
contracting myocardium and a passive tethering. Among the two sites used, the 
velocity of the lateral annulus is slightly higher than that of the septal counter 
part. Local myocardial injury might alter these regional velocities and hence 
wrongly predict myocardial motion and ventricular functions. 
 
Diastolic dysfunction is not infrequent in acute myocardial infarction and 
substantially contributes to evaluation of prognosis. Doppler echocardiography 
is the most commonly used tool in the measurement of diastolic filling of the 
left ventricle. Examination of the mitral inflow can provide us with detailed 
indices for indirectly measuring ventricular diastolic pressures and assessing 
prognosis after myocardial infarctions. 
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But, the degree of ventricular relaxation, mitral valve characteristics, 
atrial compliance factors and pressure determine the mital inflow dynamics and 
hence confounds the interpretation of the mitral inflow parameters. As a result, 
the diastolic function is poorly assessed in certain subset of patients. 
These short comings in using mitral inflow parameters can be overcome with 
the concomitant use of the Doppler indices like pulmonary venous Doppler 
inflow.  
 
The mitral annular tissue Doppler evaluation is a wonderful tool to 
correctly assist these factors which confound flow velocities. This could predict 
diastolic filling pressures reliably in many large group of patients. 
 
Determination of ventricular diastolic pressures with the use of Doppler 
techniques. 
Measurement of ventricular diastolic pressures non invasively is a useful 
adjunct in clinical assessment of decrease in ventricular compliance as exhibited 
by shortening of DT and gradually rise in E/A ratio and elevated left atrial 
pressure. 
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Ventricular systolic function also alters mitral inflow patterns. With 
normal systolic functions, DT and E/A ratios reasonably predict ventricular 
diastolic pressure and fail to do so with abnormal systolic functions. 
 
Mitral annular motion assessment using tissue Doppler is an emerging 
technique for evaluating cardiac function. The descent of the mitral annulus 
during cardiac contraction is recorded in two phases with pulse – wave Doppler. 
 
These velocities are load independent and show an excellent relationship 
to both ventricular systolic and diastolic function. 
 
E/e’ is a useful measure of ventricular diastolic pressure with reasonably 
combines both ventricular relaxation and inflow velocities. However there is a 
grey zone in the value of E/e’ between 8 to15. 
 
Non uniform ventricular relaxation especially seen in patients with 
myocardial damage could confound the relationship between ventricular 
relaxation and measurement of annular velocity. 
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Effect of  ventricular Filling Pattern on  Prognostic outcomes After MI 
The value of restrictive diastolic filling in acute myocardial infarction as 
a prognostic tool was originally studied by Oh et al (10). In his study of a group 
of patients, a higher prevalence of heart failure was seen in patients with 
restrictive filling patterns. 
 
Poulsen et al (11) in his study again confirmed these findings and 
observations in patients admitted with acute myocardial infarction. 
 
Nijland et al (12) similarly showed that patients with a DT of less than 
140 milli seconds had a reduced survival compared with patients with non 
restrictive filling patterns. 
 
Restrictive filling defect was more prevalent  in patients with older age, 
severe systolic dysfunction, and these groups are more prone for heart failure 
during the hospital stay. 
 
Irrespective of whether patients had (NSTEMI), non – ST elevation MI or 
ST elevation MI, whether they underwent thrombolytic therapy or angioplasty, 
restrictive filling, reliably predicted prognosis. 
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Clinical variables like heart failure, ventricular systolic function did not 
alter the utility of using DT as a prognostic tool. Two other studies (17,18) have 
shown that a shortened DT independently predicted worser outcomes after acute 
myocardinal infarctions over and above those routinely used prognostic factors 
like age, sex, Killip Class, ejection fraction, infarct size or wall motion scores. 
 
A DT less than 140ms or E/A less than 2 was considered restrictive 
filling and its influence on outcomes after myocardial infarctions has been 
studied in detail (22). 
 
Mild diastolic dysfunction is emerging as an independent variable 
associated with worse outcomes after myocardial infarction. Evaluation of 
diastolic pressures is more important than mere presence of diastolic 
dysfunction which nails the relationship between diastolic function and 
prognosis after acute myocardial infarction (19). 
 
Effect of elevated and diastolic pressures on the prognosis after myocardial 
infarction 
Since direct measurements of diastolic ventricular  pressures are difficult 
to obtain, non-invasive evaluation of ventricular diastolic  pressures using  E/Vp 
or E/e’ could come in handy. This was recently shown in a retrospective study 
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of a group of  patients with myocardial infarction where  an elevated E/e’ ratio 
accurately predicted mortality in addition  to EF, age, and a restrictive filling 
[19] .More  importantly, E/e’ was used for risk stratification in patients groups 
with normal  as well as abnormal ventricular  systolic function. Patients with 
pseudonormal filling (moderate increase in filling pressures)despite preserved 
LV systolic function have worser outcomes and this finding concurs with the 
results of studies in which the E/Vp ratio was used[.20,21] 
 
Left ventricular diastolic pressure and its prognostic value in acute 
myocardial dysfunction 
Elevated ventricular diastolic pressures  is associated with a high 
incidence of death  after acute MI (23–25). Higher ventricular diastolic  
pressures suggest larger area of myocardial damage with more severe systolic 
dysfunction (26-29). Morover, ventricular  pressure overload predisposes to 
ventricular, which would portend an worser outcome. 
 
Apart from its prognostic value, the evaluation of ventricular diastolic 
pressures requires invasive measurements. On the other hand, Doppler 
echocardiographic assessment of mitral flow provides us with a  non-invasive 
method  of pin pointing patients with elevated left atrial pressures . Mild 
degrees of diastolic dysfunction is shown by impaired relaxation (without 
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elevation of ventricular diastolic  pressures). This suggests that the ventricle 
takes longer to fill (lengthening of DT), augmented by the atrial component of 
diastolic filling (reducing the E/A ratio). As diastolic function worsens further it 
is associated with rising left atrial pressures. Leads to a higher diastolic gradient 
across the mitral valve, resulting in abrupt  equalization of the pressures in the 
left atrium and ventricle. 
 
Advanced diastolic dysfunction is a poor prognostic indicator portending  
with a worser outcome after acute MI, exemplified abbreviated DT which is 
very specific. They support the well-established prognostic value of clinical  
indicators of ventricular diastolic  pressures, such as Killip class. 
 
Value of E/e’ as a prognostic indicator .  
The  study by Hillis et al shows that, in the  setting of acute MI, elevated 
E/e’  reasonably  correlated with conventional transmitral Doppler evidence of 
elevated ventricular diastolic  pressure. More over it is a better prognostic 
indicator. This is in consonance with studies that demonstrated that E/e’  better 
correlated with invasive measurement of left ventricular end diastolic 
pressure.(19). E/e’ was also better  correlated with Killip class on admission 
but, emerged  to be a better  predictor of survival. Again, this is because  as 
there exists only a  limited correlation between clinical features and invasive 
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hemodynamic measurements of ventricular pressures, with the latter having 
prognostic superiority . Mitral diastolic flow velocities and DT correlate better 
with ventricular diastolic pressures in patients with impaired LV systolic 
function. But in patients with preserved LV systolic function, its value is much 
less. In contrast, the E/e’ ratio correlates well with diastolic pressure, even in 
patients with a normal LVEF (19).  An E/e’ratio >15 was the most useful 
predictor of an worse outcome, regardless of  EF , the presence or absence of 
ST-segment elevation, or drug treatment on hospital discharge. 
 
The E/e’ ratio was superior to all known measures of LV systolic 
function, such as EF and Wall motion scores, for prediction of prognosis. 
However, it is prudent to understand that measurement of E/e’provides only 
additional prognostic data, with the greatest knowledge obtained by combining 
this information with clinical, systolic, and conventional diastolic parameters. 
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MATERIALS AND METHODS 
Study centre : 
Coronary care unit of the department of cardiology , Government General 
Hospital, Chennai. 
Study design : 
Prospective ,observational  and cross-sectional study 
Study sample: 
Consecutive patients admitted in coronary care unit  between  Jan  2014 
and  March  2014 at the department of Cardiology, RGGGH, Chennai with a 
diagnosis of ,STEMI ( ST-Elevation Myocardial Infarction ).    [N = 50] 
Study Methods : 
Detailed history and cardiovascular examination was done with informed 
consent from the patient. 
Patients were followed- up from admission to hospital discharge. 
Echocardiography with color Doppler and tisuedoppler imaging of mitral valve 
will be done. The following echocardiographic parameters were studied in 
detail  within 24 hours of admission by a single operator. 
1.EF 
2.LV Dimensions 
3.Mitral  E and A velocity (m/s) 
4 Mitral  e’ velocity 
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5.Mitral E wave DT(Deceleration Time) 
6.E/e’ ratio. 
 
Stasticalanalysis : 
  All the statistics were  analysed using the SPSS version. 17 software and 
the tests used were Mean and SD, Chi-square  test , Independent t-test  and 
other relevant tools. 
 
FIG .3 -Doppler  E and A wave across mitral vavle 
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FIG. 4 -Mitral valve DT 
 
FIG .5 -Lateral annulus Tissue doppler 
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FIG.6 – Mitral e’ and a’ velocity 
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ANALYSIS OF RESULTS AND DISCUSSION 
 
Fifty consecutive patients admitted with the diagnosis of  STEMI (ST-
Elevation Myocardial Infarction ) were included in the study. Demographic 
,clinical and echocardiographic  findings of all these patients were analysed in 
detail and the following findings were observed. 
          80 % of the study population were males (n=40) and 20 % comprised of  
females (n=10). 
 
 
TABLE.1  -  SEX  DISTRIBUTION 
 
 N % Valid % Cumulative % 
Valid Male 40 80.0 80.0 80.0 
Female 10 20.0 20.0 100.0 
Total 50 100.0 100.0  
 
 
AGE  DISTRIBUTION OF PATIENTS 
The mean age of the study populationwas 56.8  years  in the overall 
group. While it was 54.9 years in the male population who entered the study it 
was higher in the female at 63.8 years .This was in conformation with all major 
studies  involving  cardiovascular events analysis. 
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 N % Valid % Cumulative % 
Valid Below 
40 4 8.0 8.0 8.0 
41-50 8 16.0 16.0 24.0 
51-60 19 38.0 38.0 62.0 
61-70 13 26.0 26.0 88.0 
Above 
70 6 12.0 12.0 100.0 
Total 50 100.0 100.0  
 
TABLE .2   AGE  DISTRIBUTION  OF PATIENTS 
RISK FACTOR ANALYSIS 
Among the commonly associated cardiovascular risk factors  smoking 
was the most frequent  associated risk factor  accounting for 56 % of the 
patients involved in the study. Diabetes mellitus and hypertension accounted for 
50 % of the patient group. Dyslipidemia was the least prevalent among the CV 
risk factors and constituted  44% of the study group. 
 
PREVALENCE  OF CV RISK FACTORS 
TABLE.3 -   SMOKING 
 N % Valid % Cumulative % 
Valid Yes 28 56.0 56.0 56.0 
No 22 44.0 44.0 100.0 
Total 50 100.0 100.0  
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TABLE .4  -DIABETES MELLITUS 
 N % Valid% Cumulative % 
Valid Yes 25 50.0 50.0 50.0 
No 25 50.0 50.0 100.0 
Total 50 100.0 100.0  
 
TABLE .5 - HYPERTENSION 
 N % Valid % Cumulative % 
Valid Yes 25 50.0 50.0 50.0 
No 25 50.0 50.0 100.0 
Total 50 100.0 100.0  
      
 
TABLE .6 - DYSLIPIDEMIA 
      N % Valid % Cumulative % 
Valid Yes 25 50.0 50.0 50.0 
No 25 50.0 50.0 100.0
Total 50 100.0 100.0  
 
REPERFUSION  STATUS 
Of  the total of  fifty patients studied, 41 patients received intravenous 
streptokinase as thrombolytic agent and pharmacological reperfusion strategy. 
9 patients did not receive any reperfusion therapy either due to delayed 
presentation ( > 12 hours) or due to contraindications. One patient was 
subjected to a delayed  invasive strategy because of  a Ventricular Septal 
Rupture and persistent hypotension. His ventricular rupture was closed with a 
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percutaneous device ( AtrialSeptalOccluder ) and  angioplasty and stenting to 
the culprit vessel  was done. 
 
TABLE.7-  REPERFUSION STATUS 
 
THROMBOLYSED 
 
NOT THROMBOLYSED 
41(n) 9(n) 
 
82% 
 
18% 
 
LOCATION OF MI 
Majority of the patients studied in the group had an anterior wall STEMI 
than an inferior wall STEMI.60% of the patients had suffered an anterior wall 
myocardial infarction in comparison to  about 40 % of the patients having 
suffered an inferior wall myocardial infarction. 
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TABLE .8 -LOCATION OF MI 
LOCATION OF MI 
 
ANTERIOR 
 
INFERIOR 
30 (n) 20 (n) 
60% 40% 
 
Of  the total of  7  deaths in the study population  4 patients  had an 
inferior myocardial infarction  and the remaining  3 patients had an anterior 
myocardial infarction. The mortality rates in their respective groups  were  10 
% and  25%. With the overall mortality at 14 % there was significantly higher 
mortality in patients who had suffered an inferior wall myocardial infarction  
than an anterior wall myocardial infarction. 
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TABLE .9 -     DISTRIBUTION OF CHARACTERISTICS 
 
 
Distribution of Characteristics 
 
The age range of patients varied, with the youngest patient of 29 years of 
age and the oldest being 90 years, with a mean of 57.1 years 
The median delay to hospital presentation also varied from 2 – 20 hours. 
The various echo cardio graphic parameters also showed varied 
distribution. 
The E value varied between 0.6 to 1.10 m/s. 
The A value varies between 0.55 to 1.10 m/s. 
E’ value varied between 4.2 to 9.6 cm/s. (mean =6.8) 
 N Minimum Maximum Mean SD 
Age in years 50 29 90 57.10 11.975 
TW (HRS) 50 2 20 8.32 4.576 
LVEDD (mm) 50 43 55 48.00 3.044 
LVESD 50 28 46 35.24 4.926 
E (m/s) 50 .60 1.10 .8108 .10949 
A (m/s) 50 .55 1.10 .7302 .10570 
e' ( cm/s) 50 4.2 9.6 6.794 1.6247 
E/e' 50 7.5 20.0 12.620 3.7509 
E/A 50 .8 1.5 1.145 .2001 
Valid N  50     
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E/e” value ranged between 7.5 to 20, with a mean of 12.62 
 
 
TABLE .10 -KILLIP CLASS 
 
 
 
 
 
 
 
 
 
 
 
KILLIP CLASS AND PRESENTATION 
 Of the total of 50 patients 44 patients presented with killip class I-II 
 The remaining 6 patients presented with killip class III-IV 
 The killip class I-II group comprised 88% of the total patients and 
killipclass III-IV group comprised 12% of the total admissions. 
 
KILLIP CLASS N % 
  
I 20 40.0 
  
II 24 48.0 
  
III 5 10.0 
  
IV 1 2.0 
  
Total 50 100.0 
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TABLE .11 - DEATH 
 
DEATH N % 
Yes 7 14.0 
No 43 86.0 
Total 50 100 
 
MORTALITY RATE 
 The mortality rate in the overall study group was 14% with  
 7 of the total 50 patients admitted had  in-hospital deathThis rate was 
slightly higher than  the routine mortality rate of about 7-  8% in our coronary 
care unit. 
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TABLE .12-  DEATH AND EJECTION FRACTION 
 
 
 
 
 
 
 
  
 
 
 
           Left ventricular systolic function is very good prognostic indicator in 
predicting in hospital mortality in patients with acute myocardial infraction. 
           In our study patients with an EF of < 45% had a mortality rate of 24% as 
against a mortality rate of only 4% for patients with an EF of > 45%. 
         This was is consonance with the results of major studies in myocardial 
infraction which higher incidence of heart failure, ventricular arrhythmias, and 
both short-term and long-term mortality rates. 
  Death Total P value 
  Yes No  
EF < 45 Count 6 19 25  
 
 
 
 
 
0.042* 
  % within 
EF 
24.0% 76.0% 100.0% 
  % within 
Death 
85.7% 44.2% 50.0% 
 > 45 Count 1 24 25 
  % within 
EF 
4.0% 96.0% 100.0% 
  % within 
Death 
14.3% 55.8% 50.0% 
Total Count 7 43 50 
 35 
 
FIGURE .7 -   DEATH AND EJECTION FRACTION 
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TABLE .13 -DT AND MORTALITY 
 
 
 
 
 
 
 
 
 
 
 
DT and Mortality 
 The mitral valve  deceleration time (DT) is an indicator of rapid filling 
phase and hence the left ventricular . With decreasing LV compliance the DT is 
shortened progressively to < 140 ms 
 In the present study, a DT of <140 ms correlated with increased mortality 
rates at 37.5% and the mortality rate was only 2.9% when the DT was > 140 ms 
In the study of Hillisetal, DT did not correlate well with mortality where it was 
only E/e’ ratio which had a better correlation with mortality. 
 In our study a DT < 140 ms was also an independent and adverse 
predictor of mortality during the in- hospital stay of the patient. 
  
Death 
P value Yes No 
DT (ms ) < 140 Count 6 10  
% within 
DT (ms ) 37.5% 62.5%  
% within 
Death 85.7% 23.3%  
> 140 Count 1 33  
% within 
DT (ms ) 2.9% 97.1% 0.001 
% within 
Death 14.3% 76.7%  
Total Count 7 43  
% within 
DT (ms ) 14.0% 86.0%  
% within 
Death 100.0% 100.0%  
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                       FIGURE .8 – DT AND MORTALITY 
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FIGURE .9 - AGE- WISE  MORTALITY 
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AGE WISE MORTALITY 
              Of the different age group of patients admitted with acute coronary 
syndrome, the mortality was highest in the age group of 70 years and above 
(50%) and no deaths in the age group below 50 years of age. 
          All the 7 deaths that occurred happened in the age group 50 years and 
above, with two deaths in the age group of 70 years and above. 
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TABLE .14 – KILLIP CLASS AND MORTALITY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
KILLIP CLASS AND MORTALITY 
             The killip class devised in the pre –thrombolytic era to predict mortality 
in patients with coronary syndromes still holds   good even in this era of 
catheter based reperfusion. 
  
Death 
P Value Yes No 
KILLIP I Count 1 19  
% within 
KILLIP 5.0% 95.0%  
% within 
Death 14.3% 44.2%  
II Count 3 21  
% within 
KILLIP 12.5% 87.5%  
% within 
Death 42.9% 48.8%  
III Count 3 2  
% within 
KILLIP 60.0% 40.0%  
% within 
Death 42.9% 4.7%     .04 
IV Count 0 1  
% within 
KILLIP .0% 100.0%  
% within 
Death .0% 2.3%  
Total Count 7 43  
% within 
KILLIP 14.0% 86.0%  
% within 
Death 100.0% 100.0%  
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The mortality was highest in the killip II-III group accounting for 85% of the 
total deaths. Since there was only one patient  admitted with killip class IV who 
was promptly treated with a percutaneous coronary intervention and device 
closure of ventricular septal rupture that patient survived to hospital discharge. 
 
FIGURE .10 – KILLIP CLASS AND MORTALITY 
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TABLE .17 – EF AND DECELERATION TIME 
 
 
 
 
 
 
 
 
 
 
DT was generally shortened in patients with ejection fraction of< 45%. 
More patients had on DT < 140 ms (n=15) if the ejection fraction was <45% 
than when it was >45% (n=1). On the other hand if the ejection fraction was 
above 45% the DT was maintained above 140 ms only 1 patient with ejection 
fraction of > 45% had on DT of < 140 ms. 
Hence normal DT had a higher positive predictive value to predict a 
higher ejection fraction > 45%. 
 
 
  
EF 
Total < 45 > 45 
DT (ms ) < 140 Count 15 1 16 
% within DT 
(ms ) 93.8% 6.3% 100.0% 
% within EF 60.0% 4.0% 32.0% 
> 140 Count 10 24 34 
% within DT 
(ms ) 29.4% 70.6% 100.0% 
% within EF 40.0% 96.0% 68.0% 
Total Count 25 25 50 
% within DT 
(ms ) 50.0% 50.0% 100.0% 
% within EF 100.0% 100.0% 100.0% 
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                      FIGURE .11– EF AND DECELERATION TIME 
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E/e’ RATIO ,ITS DISTRIBUTION AND CORRELATION. 
 
                                    TABLE .18 – DISTRIBUTION OF E/e’ 
 
E/e’ 
 
<15 
 
>15 
34 16 
68% 32% 
 
34 of the total 50 patients had an E /e’ ratio of  <15  and the remaining 16 
patients  had an E/e’ of  >15. This constituted  68% and 32% of the total study 
participants respectively. 
A majority of patients (68%) in the study group had on E/e of < 15 
indicating normal LV filling pressures. 
Among the patients with elevated filling pressures as manifested by an 
E/e’ ration of>15 nearly 88% of the patients had an abbreviated DT at < 140 ms. 
Whereas in the group with normal E/e’ ratio of < 15, only 6% had an 
shortened DT at < 140 ms .Both these findings suggest that there is a strong 
correlation between an elevated E/e’ and shortened DT. 
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TABLE.20 -   E/e’  AND  DT 
DT E/e’ 
<15 >15 
>140 32 2 
<140 2 14 
 
  
TABLE .21 - E/e’ AND DEATH 
P Value 
0.001 
E/e’ 
>15 <15 
DEATHS N 6/16 1/34 
% 37.5 2.94 
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TABLE.22 – E/e’  AND EJECTION  FRACTION 
 
EF E/e’ 
<15 >15 
<45 9 16 
>45 25 0 
 
 
E/e’ AND EJECTION FRACTION  
 None of the patients with an ejection fraction of >45 had an elevated E/e’ 
ratio. But in the patient group with a reduced ejection fraction. The E/e’ ratio 
was elevated at >15 in 64% of the total of 25 patients and was normal in the 
remaining 36% of the patients with reduced ejection fraction  group. 
E/e’ AND MORTALITY 
E/e’ had a strong correlation in predicting death as an outcome of the 
total of 16 patients with an E/e’ ratio of > 15 suggestive of elevated left 
ventricular filling pressures .6 of these patients did not survive to hospital 
discharge amounting to a mortality rate of 37.5% in that group ( Average 
mortality 14% ) 
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 In contrast in patients who had an E/e’ ratio of < 15 the mortality rate was 
low at 2.94%. 
Thus E/e’ was an independent predictor of hospital mortality in all 
patients admitted with acute myocardial infraction irrespective of baseline 
characters, risk factors and ejection fraction of the patient. 
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CONCLUSIONS   
Left ventricular systolic function has been a conventional and established 
risk stratification tool ever since echocardiography came to be used routinely in 
the setting of acute myocardial infarction (30).The present study also reliably 
highlights the fact that patients with  lower ejection fraction had a higher in 
hospital mortality compared with patients with higher or normal ejection 
fraction (31). 
 The present study used the Doppler  parameters of diastolic function of 
the left ventricle as a prognostic tool in prediction of in-hospital events in 
patients with acute myocardial infraction. 
The Doppler parameters studied were E velocity, A velocity ,E/A ratio, e’ 
tissue Doppler velocity, E wave deceleration Time and E/e’ ratio. 
E velocity, A velocity, E/A  Ratio 
 E velocity, A velocity and E/A ration in isolation did not reliaby predict 
the outcomes in patients admitted in acute coronary syndromes. They showed 
wide variations among patients with similar ejection fraction and in-hospital 
outcomes. 
 However the other indices of diastolic function like the DT(Deceleration 
Time), e’ tissue Doppler velocity of lateral mitral annulus and E/e’ ratio reliably 
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predicted in-hospital outcomes in patients with ST elevation myocardial 
infraction. 
Deceleration Time (DT) 
 In contra distinction to previous studies (19). The present study showed a 
good correlation between a reduced DT and negative patient outcomes. 6 out of 
the 7 patients who died during their in-hospital stay had a DT of  <140ms 
Similarly in the overall group of patients who had an abbreviated  DT<140ms, 
the morality rates were higher (37.5)% than in the group which had a normal 
DT  (> 140ms) (2.9%). 
A reduced DT hence predicted an elevated LV filling pressure, a large 
area of infarct and adverse in-hospital mortality trends  in patients admitted with 
acute myocardial infraction. 
e’ velocity: 
 The tissue Doppler e’ velocity of the lateral mitral annulus also reliably 
predicted outcomes in patients during their in-hospital stay. 
 In general patients who has an e’ velocity of >6 cm/s had relatively lesser 
mortality rates than in patients who had an e’ velocity of < 6cm/s 
But this factor did not correlate well with ejection fraction or Deceleration time. 
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E/e’ ratio: 
 Among the three Doppler indices which reliablypredicted the in-hospital 
outcomes in patients, E/e’ ratio was the most consistent. E/e’ reliably predicted 
in –hospital mortality, correlated better with the patient’s ejection fraction and 
also with the mitral valve deceleration time (DT). 
Patients with higher E/e’ ratio (>15) had an higher hospital mortality 
(37.5%). 
The hospital mortality rate was low at 3% in the patient groups with low 
E/e’ ratios (<15) 
 In addition, 6 out of 7 patients who dies in the hospital had an increased 
E/e’ ratio (>15) and only one patient had a reduced E/e’ ratio. 
The E/e’ ration also reliably predicted the ejection fraction. 
None of the patients with a EF of > 45% had an E/e’ ratio of >15 
While in the group with an EF of < 45% nearly 64% of patients had an 
E/e’ of >15. 
This indirectly predicted that patients with elevates E/e’ (>15) had a 
lower ejection fraction, elevated LV filling pressures as a result of larger area of 
left ventricular myocardium that has been damaged. 
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This is turn predicted poorer patients outcomes with greatly increased in-
hospital mortality rates. 
Thus E/e’ ratio can be used as a surrogate marker of elevated LV filling 
pressure and hence can be reliably used as a prognostic marker to risk strictly 
presents admitted in coronary care units over and above other non-invasive 
tools already available. 
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LIMITATIONS OF THE STUDY 
i) Smaller sample size (N=50) and hence the results of the study cannot be 
    extrapolated to general patient groups. 
 
ii) Shorter follow-up of patients during their hospital stay only and the need 
    for long term follow up to predict outcomes 
 
iii) Most patients did not undergo invasive studies [coronary angiograms and 
     measurement of LV filling pressures (PCWP) ]. 
 
iv) Only a single Echocardiographic evaluation within 24 hours of admission 
         was done and no serial follow-up studies undertaken. 
 
 
BIBLIOGRAPHY 
 
1. Becker RC, Burns M, Gore JM, et al. Early assessment and in-hospital 
management of patients with acute myocardial infarction at increased 
risk for adverse outcomes: a nationwide perspective of current clinical 
practice. The National Registry of Myocardial Infarction (NRMI-2) 
Participants. Am Heart J 1998; 135:786. 
2. Califf RM, Pieper KS, Lee KL, et al. Prediction of 1-year survival after 
thrombolysis for acute myocardial infarction in the global utilization of 
streptokinase and TPA for occluded coronary arteries trial. Circulation 
2000; 101:2231. 
3. Rea TD, Heckbert SR, Kaplan RC, et al. Body mass index and the risk of 
recurrent coronary events following acute myocardial infarction. Am J 
Cardiol 2001; 88:467. 
4. Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for 
ST-elevation myocardial infarction: A convenient, bedside, clinical score 
for risk assessment at presentation: An intravenous nPA for treatment of 
infarcting myocardium early II trial substudy. Circulation 2000; 
102:2031. 
5. Granger CB, Goldberg RJ, Dabbous O, et al. Predictors of hospital 
mortality in the global registry of acute coronary events. Arch Intern 
Med 2003; 163:2345. 
6. Morrow DA, Antman EM, Giugliano RP, et al. A simple risk index for 
rapid initial triage of patients with ST-elevation myocardial infarction: 
an InTIME II substudy. Lancet 2001; 358:1571.Wiviott SD, Morrow 
DA, Frederick PD, et al.  
7. Performance of the thrombolysis in myocardial infarction risk index in 
the National Registry of Myocardial Infarction-3 and -4: a simple index 
that predicts mortality in ST-segment elevation myocardial infarction. J 
Am CollCardiol 2004; 44:783.Wiviott SD, Morrow DA, Frederick PD, 
et al.  
8. Application of the Thrombolysis in Myocardial Infarction risk index in 
non-ST-segment elevation myocardial infarction: evaluation of 
patientsNational Registry of Myocardial Infarction. J Am CollCardiol 
2006; 47:1553. 
9. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield 
MM, Tajik AJ.  Clinical utility of Doppler echocardiography and tissue 
Doppler imaging in the estimation of    left ventricular filling pressures: 
a comparative simultaneous Doppler-catheterization study.   Circulation. 
2000;102:1788 –1794. 
10. Oh JK, Ding ZP, Gersh BJ, Bailey KR, Tajik AJ. Restrictive left 
ventriculardiastolic filling identifies patients with heart failure after acute 
myocardial infarction. J Am SocEchocardiogr. 1992;5:497–503 
11. Poulsen SH, Jensen SE, Gotzsche O, Egstrup K. Evaluation and 
Prognostic  significance of left ventricular diastolic function assessed by 
doppler echocardiography in the early phase of a first acute myocardial 
infarction. Eur Heart J. 1997;18:1882–1889. 
12. Nijland F, Kamp O, Karreman AJ, van Eenige MJ, Visser CA. 
Prognostic  implications of restrictive left ventricular filling in acute 
Myocardial  infarction: a serial Doppler echocardiographic study.J Am 
CollCardiol.1997;30:1618 –1624 
13. Cerisano G, Bolognese L, Buonamici P, Valenti R, Carrabba N, 
Dovellini EV, Pucci PD, Santoro GM, Antoniucci D. Prognostic 
implications of restrictive left ventricular filling in reperfused anterior 
acute myocardial infarction. J Am CollCardiol. 2001;37:793–799 
14. Beinart R, Boyko V, Schwammenthal E, Kuperstein R, Sagie A, 
HodH,Matetzky S, Behar S, Eldar M, Feinberg MS. Long-term 
prognostic significance of left atrial volume in acute myocardial 
infarction. J Am CollCardiol. 2004;44:327–334. 
15. Garcia-Rubira JC, Garcia-Martinez JT, Hidalgo R, Gomez-Barrado JJ, 
Rodriguez RM, Rodriguez BJ, Cruz JM. Doppler transmitral flow 
pattern is an independent prognostic factor in acute myocardial 
infarction. Cardiology.1997;88:203–206. 
16. Moller JE, Egstrup K, Kober L, Poulsen SH, Nyvad O, Torp-Pedersen 
C.Prognostic importance of systolic and diastolic function after acute 
myocardial infarction. Am Heart J. 2003;145:147–153. 
17. Temporelli PL, Giannuzzi P, Nicolosi GL, Latini R, Franzosi MG, 
Gentile F, Tavazzi L, Maggioni AP. Doppler-derived mitral deceleration 
time as a strong prognostic marker of left ventricular remodeling and 
survival after acute myocardial infarction: results of the GISSI-3 echo 
substudy. J Am CollCardiol. 2004;43:1646 –1653. 
18. Schwammenthal E, Adler Y, Amichai K, Sagie A, Behar S, Hod H, 
Feinberg MS. Prognostic value of global myocardial performance 
indices in acute myocardial infarction: comparison to measures of 
systolic and diastolic left ventricular function. Chest. 2003;124:1645–
1651 
19. Hillis GS, Moller JE, Pellikka PA, Gersh BJ, Wright RS, Ommen SR, 
Reeder GS, Oh JK.Noninvasive estimation of left ventricular filling 
pressure by E/e_ is a powerful predictor of survival after acute 
myocardial infarction. J Am CollCardiol. 2004;43:360 –367. 
20. Moller JE, Sondergaard E, Seward JB, Appleton CP, Egstrup K. Ratio of 
left ventricular peak E-wave velocity to flow propagation velocity 
assessed by color M-mode Doppler echocardiography in first myocardial 
infarction: prognostic and clinical implications. J Am CollCardiol. 2000; 
35:363–370. 
21. Moller JE, Sondergaard E, Poulsen SH, Seward JB, Appleton CP, 
Egstrup K. Color M-mode and pulsed wave tissue Doppler 
echocardiography: powerful predictors of cardiac events after first 
myocardial infarction. J Am SocEchocardiogr. 2001;14:757–763 
22. Giannuzzi P, Imparato A, Temporelli PL, et al. Doppler-derived mitral 
deceleration time of early filling as a strong predictor of pulmonary 
capillary wedge pressure in postinfarction patients with left ventricular 
systolic dysfunction. J Am CollCardiol. 1994;23:1630 –1637. 
23. Forrester J, Diamond G, Chatterjee K, et al. Medical therapy of acute 
myocardial infarction by application of hemodynamic subsets. N Engl J 
Med 1976;295:1356–62. 
24. The MulticenterPostinfarction Research Group. Risk stratification and 
survival after myocardial infarction. N Engl J Med 1983;309: 331–6. 
25. Siniorakis E, Arvanitakis S, Voyatzopoulos G, et al. Hemodynamic 
classification in acute myocardial infarction. Has anything changed in 
the last 3 decades? Chest 2000;117:1286–90. 
26. Otasevic P, Neskovic AN, Popovic Z, et al. Short early filling 
deceleration time on day 1 after acute myocardial infarction is associated 
with short and long term left ventricular remodelling. Heart 
2001;85:527–32. 
27. Johannessen KA, Cerquira MD, Stratton JR. Influence of myocardial 
infarction size on radionuclide and Doppler echocardiographic 
measurements of diastolic function. Am J Cardiol 1990;65:692–7. 
28. Pipilis A, Meyer TE, Ormerod O, Flather M, Sleight P. Early and late 
changes in left ventricular filling after acute myocardial infarction and 
the effect of infarct size. Am J Cardiol 1992;70:1397–401. 
29. Agmon M, Schlesinger Z. Serial changes in left ventricular diastolic 
indexes derived from Doppler echocardiography after anterior wall acute 
myocardial infarction. Am J Cardiol 1995;75:1272–3. 
30. Forrester J, Diamond G, Chatterjee K, et al. Medical therapy of acute 
myocardial infarction by application of hemodynamic subsets. N Engl J 
Med 1976;295:1356–62 
31. Antman EM, Braunwald E. Acute myocardial infarction. In: Braunwald 
E, editor. Heart Disease: A Textbook of Cardiovascular 
Disease.Philadelphia, PA: W.B. Saunders  9thEdition. 
 
 
 
 
 
AGE SEX SMOKER T2DM HTN DYSLIPID. PRE. MI PREV.REVAKILLIP
60 M N Y Y Y N N II
45 M Y N N Y N N II
56 M Y N Y Y N N I
68 F N Y Y Y N N II
39 F N Y Y Y N N II
41 M Y Y N Y N N II
42 M Y N N Y N N I
65 M Y N Y Y N N II
42 F N Y N N N N I
52 M Y Y N N Y N II
67 M Y Y N Y N N III
55 M Y Y N N N N III
60 M Y N N N N N II
55 M Y N N Y N N I
75 M N Y N Y N N I
42 M Y Y N N N N II
51 M Y N Y N N N I
55 M Y N N N N N I
66 M N Y Y Y N N I
54 M Y N N N N N II
51 M N N Y Y N N I
61 M Y N Y N N N II
55 M Y N Y Y N N II
55 F N Y Y Y N N II
72 F N Y Y N N N II
61 M Y N Y N N N I
68 M N Y N Y N N III
65 F N Y Y N N N II
70 F N Y N Y N N III
55 M Y Y N N N N II
60 M Y Y N Y N N I
90 F N Y Y N N N II
29 M Y N N N N N I
40 M Y N N N N N I
57 M Y N Y N N N II
67 M Y N Y N N N IV
70 M N Y Y N N N I
55 M N N Y Y N N I
48 M Y N N Y N N II
46 M N N Y Y N N I
61 M Y N Y Y N N II
65 F N Y Y N N N II
45 M N N Y N N N I
72 F N Y N N N N II
53 M Y N N Y N N I
75 M N Y N Y N N III
72 M N Y Y N N N II
60 M Y N Y Y N N II
35 M Y N N N N N I
52 M N Y N N N N I
TW (HRS) ANT.MI INF.MI SK PCI/CABG IONO I.V NTG CS DEATH
3 Y N Y N Y Y N N
18 Y N N N N Y N N
5 Y N Y N N Y N N
9 N Y Y N Y N N N
7 N Y Y N N N N N
7 Y N Y N N Y N N
3.5 N Y Y N N N N N
3 Y N Y N N Y N N
5 Y N Y N N N N N
6 N Y Y N N N N N
9 Y N Y N Y Y Y Y
6 Y N Y N Y Y N N
6 N Y Y N Y Y N N
7 N Y Y N Y N N N
16 N Y N N N Y N N
20 Y N N N Y Y N N
18 N Y N N N Y N N
7 N Y Y N N N N N
2 Y N Y N N Y N N
16 Y N N N N Y N N
3.5 N Y Y N N N N N
8 Y N Y N N Y N N
7 N Y Y N Y N N Y
8.5 Y N Y N N Y N N
16 N Y N N Y N N N
4 Y N Y N N N N N
9 Y N Y N Y Y N N
6.5 Y N Y N N N N N
9 N Y Y N Y N Y Y
11 Y N Y N Y N Y Y
7 Y N Y N N N N N
9 Y N N N N N N N
5 Y N Y N N N N N
9 Y N Y N N N N N
16 N Y N N N N N N
8 Y N Y Y Y Y Y N
6 Y N Y N N N N N
8 Y N Y N N N N N
6 Y N Y N Y N N N
2 Y N Y N N N N N
7 Y N Y N N Y N N
9 N Y Y N N Y N N
3 Y N Y N N N N N
11 N Y Y N N N N N
3 N Y Y N N N N N
12 Y N Y N Y N N Y
6 N Y Y N Y N Y Y
8 Y N Y N N Y N N
18 N Y N N N N N N
7 N Y Y N N N N Y
EF LVEDD(mmLVESD E(m/s) A (m/s) DT (ms ) e'( cm/s) E/e' MR
>45 44 30 0.72 0.66 >140 8.4 8.5 N
<45 52 42 0.86 0.9 >140 7.2 12 N
>45 46 31 0.78 0.82 >140 7 11.1 N
>45 46 32 0.75 0.8 >140 8 9.3 N
<45 52 42 0.72 0.8 >140 5.8 12.4 N
<45 51 40 0.8 0.9 >140 6.1 12 N
<45 44 29 0.8 0.72 >140 9.6 8 N
<45 48 32 0.9 0.7 <140 5.62 16 N
>45 49 31 0.7 0.6 >140 7.2 9.7 N
>45 48 33 0.75 0.6 >140 6.5 11.5 N
<45 52 42 0.72 0.82 <140 4.5 16 N
<45 51 40 0.8 0.55 <140 5.1 16 N
>45 47 32 0.76 0.8 >140 6.3 12 N
>45 45 31 0.8 0.72 >140 9.2 8.7 N
>45 44 30 0.9 0.7 <140 6.2 14.5 N
<45 51 42 0.76 0.8 <140 4.8 15.8 N
>45 43 29 0.6 0.55 >140 8 7.5 N
>45 44 28 0.77 0.6 >140 9.6 8 N
>45 44 30 0.82 0.7 >140 9.2 8.9 N
<45 48 38 0.8 0.9 >140 9 8 N
>45 44 31 0.8 0.7 >140 8.2 9.8 N
<45 48 37 0.76 0.82 >140 4.5 16.8 N
<45 46 35 0.7 0.8 <140 4.2 16.6 N
<45 48 36 0.72 0.75 >140 5 14.4 N
<45 52 42 0.75 0.6 <140 4.6 16.3 N
>45 45 32 0.8 0.7 >140 9 8.1 N
<45 49 38 1 0.7 <140 5 20 N
<45 50 40 0.9 0.7 <140 5 18 N
<45 48 36 0.9 0.7 <140 4.8 18.8 N
<45 52 43 0.9 0.7 <140 5 18 Y
>45 48 32 0.7 0.6 >140 7 10 N
<45 53 42 1 1.1 <140 6 16.6 N
>45 45 30 0.7 0.6 >140 8 8.8 N
>45 48 30 0.8 0.7 >140 6 13 N
<45 52 42 0.9 0.8 >140 8 11.2 N
<45 52 40 0.9 0.8 <140 8 11.2 N
>45 45 32 0.8 0.6 >140 7 11 N
<45 49 38 0.6 0.7 >140 6 11.6 N
<45 55 46 1 0.7 <140 5.1 20 Y
>45 45 30 0.7 0.6 >140 8 8.1 N
>45 50 35 0.7 0.8 >140 7 10 N
>45 45 31 0.8 0.7 >140 9 9 N
>45 45 32 0.9 0.7 >140 9.2 9.8 N
>45 48 32 0.7 0.8 >140 7 10 N
>45 45 32 0.9 0.8 >140 8.2 11 N
<45 52 40 1 0.7 <140 5.5 18 N
<45 48 39 1.1 0.8 <140 5.5 20 N
<45 50 41 0.7 0.8 >140 4.5 15.5 N
>45 46 32 0.9 0.6 >140 8.1 11 N
>45 48 32 1 0.8 >140 8 12.5 N
E/A
1.1
0.95
0.95
0.93
0.9
0.88
1.1
1.3
1.2
1.25
0.87
1.45
0.95
1.1
1.3
0.9
1.1
1.3
1.3
0.88
1.3
0.9
0.88
0.96
1.25
1.3
1.42
1.3
1.3
1.3
1.2
0.9
1.12
1.3
1.12
1.12
1.33
0.85
1.42
1.2
0.9
1.3
1.3
0.9
1.3
1.43
1.4
0.8
1.5
1.25
ECHOCARDIOGRAPHIC ESTIMATION OF LEFT VENTRICULAR FILLING  
PRESSURE BY E/e’ AS A PREDICTOR OF SURVIVAL AFTER  
ACUTE MYOCARDIAL INFARCTION 
 
PROFORMA 
 
Name      :            Age :    Sex : 
 
IP No. / CD No.  : 
 
 
RISK FACTORS 
 
1.  Male Gender   
2.  Smoker   
3.  Diabetes Mellitus   
4.  Hypertension   
5.  Hyperlipidemia   
6.  Previous MI   
7.  Previous Revascularisation   
 
CLINICAL CHARACTERISTICS 
 
1.  Killip Class   
2.  Median Delay   
3.  Anterior MI   
4.  Inferior MI   
5.  Thrombolytic Therapy   
 
IN‐HOSPITAL REVASCULARISATION 
 
1.   Thrombolysis  Successful   
Failed   
2.  PPCI / RESCUE PCI   
3.  DELAYED PCI   
4.  CABG   
 
 
MULTILEVEL CORONARY DISEASE  
 
 
 
IN‐HOSPITAL THERAPY & EVENTS 
 
1.  HEPARIN   
2.  I.V. NITROGLYCERIN   
3.  IONOTROPIC SUPPORT   
4.  ELECTRICAL COMPLICATIONS   
5.  MECHANICAL COMPLICATIONS   
6.  CARDIOGENIC SHOCK   
7.  DEATH   
 
 
ECHOCARDIOGRAPHIC CHARACTERISTICS 
 
S.NO.  TIMING OF ECHOCARDIOGRAPHY  ON ADMISSION  24 HOURS 
1.  LVEF (%) 
>45%     
<45%     
2.  LVEDD (mm)       
3.  LVESD (mm)       
4.  Peak E‐Wave velocity (m/s)       
5.  Peak A‐Wave velocity (m/s)       
6.  E/A Ratio       
7.  DT (ms) 
< 140     
> 140     
8.  Mitral annulus e’ cm/s       
9.  E/e’       
10.  Moderate / Severe MR       
 

